European Archives - Page 22 of 1164 - European Medical Journal

Dapagliflozin Emerges as Potential MASH Therapy in Landmark Study

Dapagliflozin shows promise for treating MASH, improving liver outcomes without worsening fibrosis in a major trial.

Showcasing Becker muscular dystrophy

Podcast series on Becker Muscular Dystrophy (BMD), exploring diagnosis, disease progression, treatment and…

Tackling Silent Liver Disease: A Global Health Priority

A 2023 global call to action by over 300 experts highlighted the need for clear, cross-specialty care pathways to support earlier identification and referral of people at risk.

UK clinical trial diversity needs work, finds ABPI

New Ipsos data shows that while 58% of UK adults are willing to join clinical trials, this drops to 41% among ethnic minority adults.

EULAR 2025: MONITOR-PsA Study Confirms Feasibility of Treat-to-Target in Routine Practice

A new analysis from the MONITOR-PsA study, presented at EULAR 2025, demonstrates that a pragmatic treat-to-target (T2T) approach in psoriatic arthritis leads to promising clinical outcomes over 48 weeks.

Bradley Monk

Onc Now: Episode 19: Key Insights from SGO 2025

Bradley Monk, Medical Director of Late-Phase Clinical Research at Florida Cancer Specialists, shares key understandings from the Society of Gynecologic Oncology (SGO) 2025, alongside a fascinating deep dive into drug approval and access.

Distinct Symptom Patterns Signal Long COVID in Young Children

New findings identify distinct symptom clusters in young children with long COVID that differ from those observed in older children and adults.

Could Non-Alcoholic Beer Be Harmful for Health?

A new study finds some non-alcoholic beers raise blood sugar and triglycerides, but pilsener appears metabolically safer.

EMJ 10.2 2025

We are delighted to share the second issue of EMJ for 2025. Featuring diverse content across multiple therapeutic areas, this issue…

EMJ's Latest Summer Journal

Discover everything you need to know in the preventative healthcare space in our latest edition, covering everything from the importance…